Imagine you wake up very early in the morning. Your room is still dark; barely any light is filtering in. You try to roll over to go back to sleep, but your muscles aren’t working. Strange. You try again, and nothing budges. At this point, you start to panic. You try to sit up, but it seems like no part of you is capable of movement. You start to panic. You try to call out for help, but even your mouth and vocal cords won’t move. Suddenly, you spot a dark figure in the corner of your room. An intense feeling of fear and dread overwhelms you. Anxiously, you keep focusing on willing yourself to move. After a few terrifying seconds, you bolt upright, finally able to sit up. The shadowy figure disappears instantly, along with your fear. You move every muscle you can think of in your body, and everything seems to suddenly work.
This is a common neurological phenomenon known as sleep paralysis. Sleep paralysis occurs during the transition between sleep and wakefulness, and it is characterized by the inability to move or speak, all while completely conscious and aware. Occasionally, sleep paralysis is also accompanied by vivid, terrifying hallucinations, and patients usually experience extreme anxiety during their first incidence. It’s likely you know someone who has experienced sleep paralysis or have even experienced it yourself, as it is estimated that one out of sixteen people have experienced sleep paralysis at least once during their lifetime. But what induces this fearful, paralyzing experience?
The muscle atonia characteristic of sleep paralysis is believed to be caused by the pathological, dissociated activation of neural pathways that typically inhibit the motor neurons in the brainstem and spinal cord during REM sleep. REM sleep is the stage of sleep often called paradoxical because the brain exhibits similar activity to wakefulness despite the individual being unconscious. It is during this stage of sleep that vivid dreams occur, and it is believed that neural activity originating from the dorsolateral portions of the pontine reticular formation inhibits motor neurons in the brainstem and spinal cord in order to prevent an individual from acting out their dreams. Sleep paralysis is marked by a dissociation between alertness and muscle atonia during the transition between sleep and wakefulness; it allows muscle atonia to persist even as one becomes conscious.
The vivid hallucinations experienced by many during sleep paralysis are also theorized to be caused by the mechanisms of REM sleep bleeding into consciousness. One hypothesis is that an imbalance in the monoaminergic-cholinergic transition between REM sleep and wakefulness causes the hallucinations. Alertness is dominated by the monoaminergic system, while REM sleep is dominated by the cholinergic system, which drives vivid dream imagery. When these two systems are out of balance, vivid hallucinations may occur during the onset or offset of wakefulness in a sleep paralysis patient. However, serotonin has also been proposed as a primary driving neurotransmitter influencing hallucinations during sleep paralysis due to its correlation with visual hallucinations.
We are still far from a complete understanding of the physiological mechanism of muscle paralysis, vivid dream imagery during REM sleep and the pathophysiology of sleep paralysis. While the exact causes of sleep paralysis are unknown, the phenomenon has been correlated with narcolepsy. Narcolepsy is a sleep disorder characterized by excessive daytime sleepiness, and an estimated 30-50% of narcoleptic patients experience sleep paralysis. Sleep paralysis is also correlated with cataplexy, which occurs in nearly half of all narcoleptic patients, and is a sudden, brief loss of muscle tone that occurs during wakefulness, often triggered by strong emotions. It is believed that sleep paralysis and cataplexy occur through similar mechanisms. Both sleep paralysis and cataplexy involve disordered activation of pathways normally associated with REM sleep during wakefullness, causing muscle atonia. This similarity might explain why sleep paralysis is more common among narcoleptic patients. Due to their correlation, future research on narcolepsy and cataplexy may reveal further insights into the phenomenon of sleep paralysis.
Sources
Ohayon, M. M., Zulley, J., Guilleminault, C., & Smirne, S. (1999). Prevalence and pathologic associations of sleep paralysis in the general population. Neurology, 52(6), 1194–1200. https://doi.org/10.1212/wnl.52.6.1194
Kornum, B. R., Knudsen, S., Ollila, H. M., Pizza, F., Jennum, P. J., Dauvilliers, Y., & Overeem, S. (2017). Narcolepsy. Nature Reviews Disease Primers, 3(1). https://doi.org/10.1038/nrdp.2016.100
GOODE, G. B. (1962). Sleep paralysis. Archives of Neurology, 6(3), 228–234. https://doi.org/10.1001/archneur.1962.00450210056006 Hishikawa Y, & Shimizu T. (1995). Physiology of REM sleep, cataplexy, and sleep paralysis. PubMed, 67, 245–271.
Bhalerao, V., Gotarkar, S., Vishwakarma, D., & Kanchan, S. (2024). Recent insights into sleep paralysis: Mechanisms and management. Cureus. https://doi.org/10.7759/cureus.65413
Ortiz, L. E., Morse, A. M., Krahn, L., Lavender, M., Horsnell, M., Cronin, D., Schneider, B., & Gudeman, J. (2025). A survey of people living with narcolepsy in the USA: Path to diagnosis, quality of life, and treatment landscape from the patient’s perspective. CNS Drugs, 39(S1), 23–36. https://doi.org/10.1007/s40263-024-01142-8
D’Agostino, A., Limosani, I. (2010). Hypnagogic Hallucinations and Sleep Paralysis. In: Goswami, M., Pandi-Perumal, S., Thorpy, M. (eds) Narcolepsy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0854-4_8
Jalal, B. (2018). The neuropharmacology of sleep paralysis hallucinations: Serotonin 2A activation and a novel therapeutic drug. Psychopharmacology, 235(11), 3083–3091. https://doi.org/10.1007/s00213-018-5042-1
